$AMZN | Wells Fargo 𝗺𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝘀 𝗢𝘃𝗲𝗿𝘄𝗲𝗶𝗴𝗵𝘁 on 𝗔𝗺𝗮𝘇𝗼𝗻.𝗰𝗼𝗺, cuts PT to $𝟯𝟮𝟵 from $𝟯𝟯𝟴 Analyst sees AWS acceleration driving revenue and operating-income guidance above Street despite fuel and wage headwinds.

$NVDA - NVIDIA: GOLDMAN EXPECTS STOCK TO STAY RANGE-BOUND Goldman Sachs reiterated its Buy rating on NVIDIA with a $285 price target after a solid quarter and guidance above Wall Street expectations. However, elevated expectations could keep shares range-bound near term. Key investor focus: NVIDIA’s $1T data-center revenue target, $500B partner financing platform, future gross margins, and demand for CPU-only racks driven by agentic AI.

$AAOI AAOI needs another 59% revenue jump next quarter just to meet the Street's forecast. Tonight's Q4 outlook may matter more than a Q3 beat. Q3 reports after the Nov 5 close; the call starts at 4:30pm ET. 1. The bar Yahoo Finance consensus, checked Nov 5: Q3 revenue $268.1M; normalized EPS $0.14. Q4 revenue $427.3M; normalized EPS $0.56. Revenue/EPS coverage: 5/6 analysts. AOI's Q3 guide: revenue $255–290M, adjusted EPS $0.11–0.26 on about 92.8M diluted shares, and adjusted gross margin 29–30.5%. 2. The profit test The revenue-guide midpoint implies 42% growth from Q2's $191.9M. The gross-margin midpoint is 29.75%, essentially flat against Q2's 29.8%. More shipments should spread fixed operating costs across more revenue. We'd want to see that translate into stronger earnings and cash generation. 3. Our questions Q1: Does Q4 guidance support the $427M revenue/$0.56 EPS consensus? Q2: How much growth comes from 800G, and when does 1.6T become material revenue? Q3: Is the year-end target of roughly 650,000 800G/1.6T units of monthly capacity still on track, and how much is usable, qualified output? Q4: Do margins and cash flow improve as production scales? What share count follows the latest equity raise? The $600M ATM completed in October brought in about $588M net. Funding is available; execution and returns on that capital still need proving. 4. What would change our view Bull: Q3 above $290M and $0.26, with Q4 guidance above consensus and improving margins; the strongest upside setup. Base: Q3 within the guide; Q4 outlook and margins decide direction. Bear: Q3 below $255M and $0.11, or Q4 below consensus; downside risk even if Q3 beats. At 2:13pm ET: $48.15, down 18.7% (Alpaca IEX). A delayed Nov 6 $50 straddle snapshot cost about $8.65 at mid, roughly 18% of that spot price. We'd look for Q4 delivery and profitability to improve together before treating a Q3 beat as confirmation of the ramp.

$AXTI reports Q3 after the close today. My read: a beat is possible, but the $66M / $0.31 quarter is already in the price. The stock needs evidence that AXT can turn its 2027 capacity plan into permitted, profitable shipments. Start with the bar. AXT reported $47.6M of Q2 revenue, $0.19 of non-GAAP EPS and a 44.9% GAAP gross margin. Indium phosphide contributed a record $30.7M. For Q3, management identified approximately $66M of revenue it could realize from products that either had export permits in hand or did not need one. It guided to $0.29–0.31 of GAAP EPS and $0.30–0.32 non-GAAP. Yahoo's current consensus is $66.0M and $0.31. That distinction matters. AXT's guide is a high-confidence floor, but Wall Street has already copied the floor into its model. Reporting $66M and $0.31 would mean the company delivered what it laid out. It would not answer how much additional demand can clear the permit gate. There is room for upside. One quarter earlier, AXT entered Q2 with roughly $34M of realizable revenue under the same permit-or-no-permit framing and finished at $47.6M. I would not mechanically apply that 40% uplift again. Permit timing remains outside the company's control, and the Q3 base is much larger. Still, it explains why the headline consensus can be beaten. The first number I will check is gross margin. Q2 reached 44.9% as InP volume absorbed fixed costs and lifted mix. On the call, management told analysts to stay around 45% for Q3, while saying its internal target begins with a four and could eventually begin with a five. A revenue beat with gross margin below 43% would tell me the ramp is costing more than expected. A result around 44–46% would preserve the current economics. At 47% or above, pricing, diameter mix and utilization would be compounding faster than the market model. The second number is Q4 guidance. Consensus currently sits at $77.45M of revenue and $0.36 of EPS. My base range is $75–80M. Below $75M would suggest permits or the capacity ramp are interrupting the trajectory. Above $80M would matter more than a small Q3 beat because it moves the exit rate. The third test is 2027. Management said it was targeting about $60M of quarterly InP capacity exiting 2026 and roughly $130M exiting 2027. The wording on the latter was loose: an executive referred to “revenue” while answering a capacity question, and analysts immediately repeated it as capacity. I treat $130M as a production-value target, not booked quarterly revenue. Demand visibility is real but does not remove the execution gap. Backlog was already above $100M in July. AXT said it extended into 2027, and long-term supply agreements reached further. Casela and Coherent prepaid $22.3M and $25.4M for supply. Those are stronger signals than a non-binding forecast, but capacity is still not revenue. AXT must install and qualify output, secure export permits for overseas customers and protect yield while it scales. That is also why the customer mix matters. China represented more than half of Q2 revenue and domestic shipments do not face the same export-permit gate. Faster China sales can produce a clean quarter while leaving the North American bottleneck unresolved. I want management to separate volume growth from permit progress rather than blend the two into one demand statement. At the Oct. 29 snapshot price of $62.94, the stock trades at roughly 28x the unchanged $2.25 2027 EPS consensus. The valuation is no longer asking whether Q3 revenue can reach $66M. It is asking whether the company can climb from a $60M quarterly InP capacity exit rate this year toward $130M next year without losing margin or access to overseas customers. My scorecard is simple: • Bear: revenue below $66M, gross margin below 43%, Q4 guide below $75M, or weaker permit language. • Base: $66–70M, 44–46% gross margin and a $75–80M Q4 guide, with the 2027 capacity path intact. • Bull: revenue above $70M, gross margin at least 47%, Q4 guidance above $80M and new evidence that 2027 capacity is funded by customer commitments. I expect the quarter itself to be solid. The trade turns on whether management can put dates, permits and customer commitments behind the 2027 number.